Published Date: 01 Mar 2023
USA: For the evaluation of hepatic steatosis in obese patients, photon computed tomography (PCCT) is as effective as magnetic resonance imaging (MRI).
Read Full NewsSanofi's tolebrutinib fails to meet key trial endpoints for multiple sclerosis, delaying FDA review and raising questions about its future in treatment.
Neal K. Shah talked about how social robots could support emotional well-being in patients with neurologic conditions by reducing loneliness and promoting engagement in health-related activities.
Christopher Kenney, MD, FAAN, chief medical officer at Xenon Pharmaceuticals, reviews encouraging long-term data behind azetukalner, a first-in-class Kv7 channel opener, as a potential treatment for focal onset seizures.
This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.
Chronic Pain Associated With Significantly Reduced Ability to Relax Muscles
Global Data Suggest Increased Prevalence of Focal Segmental Glomerulosclerosis
Older Patients on Maintenance Dialysis Underrepresented in RCTs
1.
Remote monitoring can improve recovery from cancer surgery
2.
Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.
3.
Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.
4.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
5.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
1.
Unveiling the Complexity of Multiple Myeloma Staging
2.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
3.
HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation